Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Other Gross PP&E Adjustments: 2020-2025

Historic Other Gross PP&E Adjustments for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to -$7.2 million.

  • Harmony Biosciences Holdings' Other Gross PP&E Adjustments rose 13.17% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 8.40%. This contributed to the annual value of -$2.1 million for FY2024, which is 9.47% up from last year.
  • Harmony Biosciences Holdings' Other Gross PP&E Adjustments amounted to -$7.2 million in Q3 2025, which was up 45.53% from -$13.2 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Other Gross PP&E Adjustments peaked at -$2.1 million during Q4 2024, and registered a low of -$21.0 million during Q1 2022.
  • In the last 3 years, Harmony Biosciences Holdings' Other Gross PP&E Adjustments had a median value of -$13.2 million in 2025 and averaged -$11.9 million.
  • The largest annual percentage gain for Harmony Biosciences Holdings' Other Gross PP&E Adjustments in the last 5 years was 29.90% (2022), contrasted with its biggest fall of 85.63% (2022).
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Other Gross PP&E Adjustments stood at -$3.3 million in 2021, then increased by 29.90% to -$2.3 million in 2022, then dropped by 1.38% to -$2.3 million in 2023, then climbed by 9.47% to -$2.1 million in 2024, then grew by 13.17% to -$7.2 million in 2025.
  • Its last three reported values are -$7.2 million in Q3 2025, -$13.2 million for Q2 2025, and -$19.6 million during Q1 2025.